Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells.

O'Reilly MK, Tian H, Paulson JC.

J Immunol. 2011 Feb 1;186(3):1554-63. doi: 10.4049/jimmunol.1003005. Epub 2010 Dec 22.

2.

Multivalent ligands for siglecs.

O'Reilly MK, Paulson JC.

Methods Enzymol. 2010;478:343-63. doi: 10.1016/S0076-6879(10)78017-4.

3.

Chemically tailored multivalent virus platforms: from drug delivery to catalysis.

Udit AK, Hackenberger CP, O'Reilly MK.

Chembiochem. 2010 Mar 1;11(4):481-4. doi: 10.1002/cbic.201000001. No abstract available.

PMID:
20127782
4.

Siglecs as targets for therapy in immune-cell-mediated disease.

O'Reilly MK, Paulson JC.

Trends Pharmacol Sci. 2009 May;30(5):240-8. doi: 10.1016/j.tips.2009.02.005. Epub 2009 Apr 7. Review.

5.

Bifunctional CD22 ligands use multimeric immunoglobulins as protein scaffolds in assembly of immune complexes on B cells.

O'Reilly MK, Collins BE, Han S, Liao L, Rillahan C, Kitov PI, Bundle DR, Paulson JC.

J Am Chem Soc. 2008 Jun 18;130(24):7736-45. doi: 10.1021/ja802008q. Epub 2008 May 28.

6.

On-virus construction of polyvalent glycan ligands for cell-surface receptors.

Kaltgrad E, O'Reilly MK, Liao L, Han S, Paulson JC, Finn MG.

J Am Chem Soc. 2008 Apr 9;130(14):4578-9. doi: 10.1021/ja077801n. Epub 2008 Mar 15.

7.
8.
9.

Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization.

Zhao L, O'Reilly MK, Shultz MD, Chmielewski J.

Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.

PMID:
12643937
10.

Neoglycopeptides as inhibitors of oligosaccharyl transferase: insight into negotiating product inhibition.

Peluso S, de L Ufret M, O'Reilly MK, Imperiali B.

Chem Biol. 2002 Dec;9(12):1323-8.

Supplemental Content

Loading ...
Support Center